Pulmonary Hypertension Clinical Trials in Albuquerque, New Mexico

4 studies are recruiting for pulmonary hypertension in Albuquerque, New Mexico right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of New Mexico, Albuquerque, New Mexico
    Locations
    37 in total
    Run by
    Tempus AI

    See if you can join NCT06911632 on ClinicalTrials.gov

  2. A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Clinical Research Site, Albuquerque, New Mexico
    Locations
    13 in total
    Run by
    Pulmovant, Inc.

    See if you can join NCT07333183 on ClinicalTrials.gov

  3. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of New Mexico Health Sciences Center, Albuquerque, New Mexico
    Locations
    71 in total
    Run by
    United Therapeutics

    See if you can join NCT06388421 on ClinicalTrials.gov

  4. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

    Stage
    Not phased
    Ages
    18 and older
    Site
    New Mexico Heart Institute, Albuquerque, New Mexico
    Locations
    68 in total
    Run by
    Abbott Medical Devices

    See if you can join NCT06526195 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.